Taking this evidence into consideration, it can be speculated that LGG tumours may suppress the activity of beneficial tumour-infiltrating CD56dim NK cells through the HLA-E/CD94-NKG2A signalling axis. The gene discussed is KLRD1; the disease is neoplasm.